Lexaria Bioscience Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed on June 22, 2009, by Lexaria Corp. (Nevada), reporting a corporate action effective June 23, 2009. The company is headquartered in Vancouver, British Columbia, Canada.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a capital structure change.
Material Changes
- Share Consolidation: A 4-for-1 reverse stock split of authorized and issued common stock.
- Authorized Capital: Decreased from 75,000,000 shares to 18,750,000 shares.
- Outstanding Shares: Decreased from 24,369,500 shares to 6,092,375 shares.
- Par Value: Remains at $0.001 per share.
- Trading Details: The consolidation became effective on the Over-the-Counter Bulletin Board on June 23, 2009, under the new symbol "LXRP" and CUSIP number 52886N 208.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, or contingencies beyond the execution of the share consolidation.
Investor Verification Checklist
- Confirm the new trading symbol "LXRP" and CUSIP 52886N 208 on the Over-the-Counter Bulletin Board.
- Verify the adjusted share count of 6,092,375 outstanding shares in brokerage accounts.
- Review the attached Certificate of Change (Exhibit 3.01) for legal confirmation of the capital reduction.